Status:
COMPLETED
Naltrexone Treatment for Alcoholism
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Conditions:
Alcoholism
Eligibility:
All Genders
30-55 years
Phase:
PHASE4
Brief Summary
This study will evaluate the effectiveness of the medication naltrexone (Revia) for treating alcoholism. Individuals will be inpatients for a 2 week period and provide assessments of their alcohol wit...
Eligibility Criteria
Inclusion Criteria:
- Meets criteria for alcohol dependence.
- Committed to alcohol abstinence as a treatment goal.
- Individuals will be required to identify two family members or close friends who are knowledgeable about their location, drinking behavior, and psychosocial status.
Exclusion Criteria:
- Meets criteria for any other psychoactive substance use disorder (excluding nicotine and caffeine).
- Meets criteria for a major psychiatric disorder and are in need of or currently undergoing pharmacotherapy.
- Females who are pregnant, lactating, or not using a reliable method of contraception.
- Currently experiencing a serious medical condition that would place them at risk or interfere with study participation.
- Experiencing acute hepatitis or liver failure or whose liver function test is more than 3 times normal.
- Have a history of severe allergies, multiple adverse drug reactions or known allergy to naltrexone.
- Vocabulary below the 5th grade reading level.
- Abnormal MRI scan.
- HIV infection due to the neurological sequelae.
- Significant central nervous system diseases.
- Seizure disorder or history of closed head trauma.
- Neuroendocrine disorders.
- Treatment with opiates within the last six months.
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
March 1 2003
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT00000438
End Date
March 1 2003
Last Update
May 14 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21205